Figure 5From: Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/mlFour-year biochemical relapse-free survival in patients with radiotherapy (RT) dose ≥ 64 Gy and that in patients with RT dose < 64 Gy.Back to article page